We will never compete with Hologic without an Endometrial Ablation Device. TruClear needs a companion product to compete with Myosure. The Minerva Device is kicking butt. The Cleveland Clinic system just voted to go 100% Minerva. I hope someone from MDT management is reading this and gets Minerva. The last thing we need is the Aegea Stanley Steamer that has worse efficacy than a Novasure. Steam is just hotter water, so why would this product be any more successful than a HTA, the hot water product. Voila! It has the same efficacy data as HTA in the FDA clinical study. TruClear and a Minerva.... Please!!
Let’s not waste the $350 million we paid for a TruClear.
Let’s not waste the $350 million we paid for a TruClear.